Get Patent Opposition Report for Amylin Pharmaceuticals

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore Amylin Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2341905Sep 13, 2023Sustained Release Formulations Using Non-Aqueous Carriers2
EP2347762May 8, 2019Exendin For Treating Diabetes And Reducing Body Weight4